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Upon exposure  to  follicle-stimulating  hormone 
(FSH), the gonadotropin-responsive Sertoli cell ex- 
presses  increased  rolipram-sensitive CAMP-specific 
phosphodiesterase (CAMP-PDE) activity. To under- 
stand  the mechanisms leading  to  this  activation,  the 
CAMP-PDEs present  in  the  Sertoli cell were  character- 
ized and  their  regulation  studied. Comparison of the 
conceptual translates of two groups of PDE cDNA 
clones  isolated from a Sertoli cell cDNA library 
(ratPDE3  and  ratPDE4) showed that  the encoded pro- 
teins  were  structurally  similar,  containing a core  re- 
gion of 455 amino  acids  with a sequence  identity of 
87%. The  amino  and  carboxyl  termini  were  divergent. 
Expression of these cDNAs in Escherichia coli and 
monkey COS-7 cells demonstrated that the encoded 
CAMP-PDEs  had similar  affinities  for  the cAMP sub- 
strate  and  were qually  sensitive  to a number of PDE 
inhibitors  (rolipram > Ro 20-1724 > cilostamide).  FSH 
stimulation of the  Sertoli cell produced an  increased 
rate of transcription of the  ratPDE3 gene and  elevated 
mRNA levels for  ratPDE3  and  to a lesser extent of 
ratPDE4.  The  increase  in mRNA levels  was  detected 
after 1 h of stimulation.  Forskolin,  cholera  toxin, and 
M,02’-dibutyryl cAMP produced a similar  increase  in 
rate of transcription  and  elevated mRNA levels,  indi- 
cating  that  this  activation is mediated  by an  increase 
in  intracellular CAMP. RatPDE4 mRNA levels were 
maximal  upon  exposure  to 10 ng of FSH/ml, whereas 
ratPDE3 mRNA levels could be further  elevated  with 
higher FSH concentrations. The intensity of an im- 
munoreactive  band  with  characteristics  identical  to a 
purified CAMP-PDE, correlated with the increased 
cAMP  hydrolytic  activity after FSH or dibutyryl 
cAMP treatment,  demonstrating  that  changes  in 
CAMP-PDE protein  levels are involved in  this  regula- 
tion.  These data provide  evidence that multiple CAMP- 
PDE  forms are expressed  in the  rat  Sertoli cell. Al- 
though  differences  in the  pattern of activation of these 
forms  were  observed,  these  data  show,  that  in  the rat 
Sertoli cell, the CAMP-PDE activity is regulated by 
hormones  via a novel  mechanism that involves a 
CAMP-dependent activation of transcription of a PDE 
gene. 
* This work was supported by National  Institutes of Health  Grant 
HD20788. The costs of publication of this  article were defrayed in 
part by the  payment of page  charges. This  article  must  therefore be 
hereby  marked “advertisement” in  accordance  with 18 U.S.C. Section 
1734 solely to indicate  this  fact. 
The nucleotide  sequence(s)  reported in  this  paper has been  submitted 
to  the  GenBankTM/EMBL  Data  Bank  with accession  umber($ 
$ To whom correspondence should be addressed  Laboratories for 
Reproductive Biology, CB 7500 MacNider 202H, University of North 
Carolina,  Chapel Hill, NC 27599. Tel.: 919-966-6795. 
MZ35349-M25350. 
The responsiveness of the  target cell to  hormones is contin- 
uously adjusted  in  synchrony  with  changes  in  the  extracellular 
environment. The mechanisms involved in this adaptation 
are complex and involve changes  in  the  components of the 
signal  transduction  machinery at  the  plasma  membrane level 
as well as changes in the enzymes involved in intracellular 
signalling. Phosphodiesterases  (PDEs),’  the enzymes that 
degrade cyclic nucleotides might play an important role in 
these processes. In  most cells,  including the  Sertoli cell ( l ) ,  
degradation of cyclic nucleotides is  carried  out by multiple 
PDEs  with  different  properties  in  terms of affinity for cAMP 
and  cGMP, regulation of hydrolytic activity,  and  sensitivity 
to  inhibitors  (2). Although  several types of PDEs  are able to 
hydrolyze CAMP, it is now recognized that two families of 
PDEs have a high affinity for this nucleotide. One of these 
forms,  referred  to  as  cGMP-inhibited  PDE is sensitive  to  the 
selective inhibitor cilostamide and  the  cardiotonic  milrinone 
(2).  In several cell types,  this enzyme is membrane  bound  and 
rapidly activated by insulin and P-adrenergic agonists (3). 
The  other  type,  termed CAMP-specific PDE  (CAMP-PDE) is 
insensitive  to  cGMP  and  is selectively inhibited by the  anti- 
depressant rolipram (2). Also this latter form of PDE has 
been  shown to  be  regulated by hormones. In  the  Sertoli cell, 
FSH via an  increase  in  cAMP  causes  the  activation of a PDE 
with the  properties of a CAMP-PDE  (1,4).  Similar  hormone- 
dependent regulation of cAMP hydrolyzing activity  has also 
been  demonstrated  in glioma and  astrocytoma cell lines (5- 
8), in  fibroblasts  (9, lo),  granulosa  (11),  and  lymphoma cells 
(12).  The  CAMP-PDE which in  the  rat  Sertoli cell is stimu- 
lated by FSH, is thought  to be involved  in the  refractoriness 
that follows hormone  stimulation (13-15). It  is now clear  that 
the family of the  CAMP-PDEs  is composed of multiple related 
forms. Molecular cloning data (16-18) have demonstrated 
that  in  the  rat  there  are  at  least four  genes  encoding cAMP 
phosphodiesterases which  have  b en highly conserved 
through evolution  (16, 17). It  has been  shown that  the  steady 
state  mRNA level for one of these  PDEs  (ratPDE3) is regu- 
lated by hormones  and  cAMP  (19).  Here we have studied  in 
detail  the  mechanisms involved in  this regulation. In  addition, 
the  finding  that  another  CAMP-PDE gene (ratPDE4)  is  ex- 
pressed  in  the  Sertoli cell prompted  us  to  study  the  properties 
and the regulation of this  latter  PDE  in response to  FSH. 
Here we report  that  the expression of both  these  structurally 
related  CAMP-PDEs  is  under  the  control of hormones.  We 
show that differences in expression  occur at  least  in  part  at 
the level of gene transcription  and  that  an increase in  PDE 
activity follows changes in PDE  protein  concentration. 
The abbreviations used  are: PDE, cyclic nucleotide phosphodies- 
terase;  CAMP-PDE, CAMP-specific phosphodiesterase; SDS, sodium 
dodecyl sulfate; Bt2cAMP, N‘,OO”-dibutyryl CAMP; FSH, follicle- 
stimulating  hormone;  EGTA, [ethylenebis(oxyethylenenitrilo)]tetra- 
acetic  acid;  PBS,  phosphate-buffered  saline. 
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EXPERIMENTAL PROCEDURES 
Materials 
Crotalus atrox snake venon and lysozyme were purchased from 
Sigma;  Pansorbin cells from  Behring Diagnostics; Ro 20-1724 (4-(3- 
butoxy-4-methoxybenzyl)-2-imidazolidinone) was from Hoffmann- 
LaRoche; rolipram (4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyr- 
rolidone) was from  Berlex, NJ;  cilostamide  (N-cyclohexy-4-[(1,2- 
dihydro-2-oxo-6-quinolyl)oxy]-N-methylbutyramide) was  provided 
by Dr. H. Hidaka, Nagoya University School of Medicine, Showa- 
Ku, Nagoya 466 Japan; AG 1-X8 resin was obtained  from  Bio-Rad 
[2,8-,”H]cAMP (20-50 Ci/mmol), ‘*‘I-labeled protein A (2-10 pCi/pg), 
[&”P]CTP (3000 Ci/mmol), and [a-”PIUTP (800 Ci/mmol) were 
purchased from Du Pont-New  England  Nuclear;  guanidium  thiocya- 
nate from Fluka; CsCl from  Gallard  and Schlesinger;  immobilon  from 
Millipore; Biotrans from ICN; a random primed DNA labeling kit 
was purchased from Boehringer Mannheim; p2523 columns from 
5prime-3prime;  and  dextran  sulfate M ,  500,000 was  from Pharmacia. 
Sequence  Analysis 
The cloning of PDEs from a rat  Sertoli cell cDNA  library  has been 
described (16). The complete  ratPDE3  DNA  sequence  (19)  and also 
a partial cDNA  sequence of two ratPDE4  clones have  been published 
(16). These clones have been completely sequenced and also two 
additional ratPDE4 clones (ratPDE4.3 and ratPDE4.4) have been 
partially  characterized. The sequences  were  aligned using  the 
MicroGenie  software  package (Beckmann). 
Prokaryotic Expression 
To express  ratPDE3  and  ratPDE4  cDNAs  in  bacteria,  the  prokar- 
yotic expression  vector pRC23  (20)  (kindly provided by Dr. R. Crowl) 
was used. This vector contains  the h phage PL promoter followed by 
a ribosome-binding site and an EcoRI cloning site. The distance 
between  the  ribosome-binding  site  and  the AUG codon is  critical for 
efficient translation (21). Because the EcoRI site in cDNA clone 
ratPDE3.1 precedes the  putative  initiation AUG codon  by 150  bases 
(19), a new EcoRI site was created 3 bases 5’ of the AUG by the 
polymerase chain reaction. cDNA clone ratPDE4.2 starts with an 
GcoRI site 5 bases  upstream of the  putative AUG and was ligated 
into  the EcoRI site of pRC23  without  further  manipulation.  Esche- 
richia coli DH5a bacteria were transformed (22) with the pRC23 
compatible plasmid pRK248cIts (provided by Dr. R. Crowl) which 
encodes a temperature-sensitive hcIAt2 repressor (23) and confers 
tetracyclin  resistance  to  the cells. Tetracyclin  resistant  pRK248cIts 
containing DH5a bacteria were transformed with the pRC23-rat- 
PDE3  and  pRC23-ratPDE4  constructs  and grown in  the  presence of 
ampicillin  (the selectable marker of pRC23) a t  30 “C.  Expression of 
the  ratPDEs by shifting  the  temperature  from  30  to 42 “C for 3 h  was 
monitored by polyacrylamide gel electrophoresis followed by Coo- 
massie  Brilliant  Blue  staining or Western  blot  analysis  (with K l l l  
antiserum, see below) and  PDE assays. For PDE assay, the  bacteria 
were  pelleted, resuspended  in 20 mM Tris  and 1 mM EDTA,  and lysed 
with 5 mg/ml of lysozyme. The solution was adjusted to 0.2 mM 
EGTA, 50 mM benzamidine, 0.5 pg/ml leupeptin, 0.7 pg/ml pepstatin, 
and 2 mM phenylmethylsulfonyl fluoride. 
Eukaryotic Expression 
The pCMV5 expression in vector (24) drives the expression of 
cDNAs cloned into  the  multiple  cloning  site  in  between  the  human 
cytomegalovirus  major immediate  early gene promoter  and  enhancers 
and  the  transcription  termination  and  polyadenylation  signals of the 
human growth hormone. The  ratPDE3.1  and  ratPDE4.1  cDNAs were 
inserted into the EcoRI site of the plasmid. After transformation, 
ampicillin-resistant  DH5a  bacteria were tested for the  presence  and 
the  orientation of the  ratPDE  cDNAs.  Plasmids were prepared from 
1 liter of bacterial cultures using p2523 columns according to the 
protocol of the manufacturer. Monkey kidney cells (COS-7) were 
grown in high glucose Dulbecco’s modified Eagle’s medium containing 
5% (v/v) fetal calf serum. When the cells reached a density of 
approximately 40% of confluency, the medium was aspirated and 
medium  without  serum was added. The cells were transfected  using 
the DEAE-dextran method (25) with 10 pg of plasmid DNA. Four 
hours  after  the  addition of the  DNA  the cells were treated  with 10% 
dimethyl sulfoxide in  phosphate-buffered  saline (PBS), rinsed  with 
PBS,  and  incubated  in complete  medium  for  48 h.  “Mock”  transfected 
cells were treated exactly the  same way but  did  not receive DNA. The 
cells were rinsed  with PBS  and lysed for RNA  extraction,  or collected 
with a rubber policeman and homogenized in an all-glass Dounce 
homogenizer in a  buffer containing 20 mM Tris.Cl  (pH 8.01, 10 mM 
EDTA, 0.2 mM EGTA,  50 mM benzamidine, 0.5 pg/ml leupeptin, 0.7 
pg/ml pepstatin,  and 2 mM phenylmethylsulfonyl fluoride  (homoge- 
nization buffer). After centrifugation for 15 min a t  14,000 X g, the 
supernatant  and  the  pellet  fractions were subjected to  Western blot 
analysis,  immunoprecipitation,  or  PDE  assay. 
Sertoli Cell Cultures 
Sertoli cell cultures from 15- to 17-day-old Sprague-Dawley rats 
were prepared  as described (26)  and  maintained  in medium without 
serum for 4  days. On  the  fourth  day of culture  the cells were rinsed 
with Hank’s balanced salt solution, the medium was replaced and 
FSH  (NIDDK  ov-FSH  S16), N6,O””dibutyryl CAMP, forskolin,  chol- 
era  toxin, or vehicle were added  to  the medium. At  the  indicated  time 
after  treatment,  the cells were rinsed twice with PBS and lysed for 
RNA  extraction.  For  immunoprecipitation,  Western  blot  analysis,  or 
PDE  assay,  the cells were scraped  in homogenization buffer with a 
rubber policeman and homogenized in  an all-glass  Dounce homoge- 
nizer.  Cellular fractions were prepared by centrifugation at 14,000 X 
g for 15 min. 
PDE Assay 
PDE assays were performed basically as described (27) and as 
detailed previously (19). Cell extracts  in homogenization  buffer were 
adjusted to 40 mM Tris.Cl (pH 8.0), 10 mM  MgC12, 1.25 mM 2- 
mercaptoethanol, and 1 p~ [“HICAMP (0.1 pCi/reaction). After in- 
cubation a t  34 “C for 3-10 min the reactions were terminated by 
addition of 1 volume of a 40 mM Tris. C1 (pH 7.5) solution  containing 
10 mM EDTA  and  heat  denaturation.  To  each  reaction  tube 50 pg  of 
C. atrox snake venom was added. After incubation a t  34 “C for 20 
min  the  reaction  products were separated by anion exchange chro- 
matography  on AG 1-X8 resin  and  the  amount of released radiola- 
beled adenosine was quantitated by scintillation  counting. PDE  ac- 
tivity  determinations were performed  in  triplicate  at  three  different 
time  intervals.  For  the  inhibitor  studies, cell extracts were incubated 
in  the  presence of lo-” to lo-’ M Ro 20-1724, rolipram, or cilostamide 
which were dissolved in  dimethyl sulfoxide. Control  tubes  contained 
equal  amounts (2.5%) of dimethyl sulfoxide. For the  determination 
of the K,  of the enzyme (28) cell extracts were incubated  with  0.1 
pCi of [“HICAMP  and 0.1-50 p~ unlabeled cAMP for 2, 4, 6, and 8 
min. The  PDE  activity is expressed  as  the  rate of cAMP hydrolysis/ 
min. 
RNA Extraction and Northern Blot Analysis 
Total  RNA was prepared  as described (29).  Sertoli  or COS-7  cells 
were lysed in a buffer containing  50% (w/v) guanidine thiocyanate, 
16.7 mM Na citrate, 0.5% (w/v) Na lauryl sarcosine, 80 mM 2- 
mercaptoethanol,  and 0.1% (v/v) Sigma antifoam A. This cell lysate 
was  layered on  top of a solution  containing  5.7 M cesium  chloride and 
167 mM Na  acetate  (pH 5.0) (30).  The  RNA was pelleted by centrif- 
ugation for 16 h a t  100,000 X g. After centrifugation  the RNA  pellet 
was redissolved in ddH,O and ethanol precipitated. Poly(A)’ RNA 
was prepared by oligo(dT)-cellulose chromatography as described 
(31). Five micrograms of poly(A)+ RNA or 10-20 pg of total  RNA 
was denatured by incubation a t  50  “C for 1 h in a  buffer containing 
50%  (v/v)  dimethyl sulfoxide,  20% (v/v) glyoxal, and 20 mM sodium 
phosphate  (pH 6.8) (31).  After  separation  on a 1% agarose gel in 10 
mM sodium  phosphate  (pH 6.8), the gel was blotted  onto a Biotrans 
nylon membrane  (32)  and  baked a t  80  “C for 1 h. Blots were prehy- 
bridized in 50% v/v)  formamide, 50 mM sodium phosphate  (pH 6.5), 
5 X SSC  (20 X SSC, 3 M NaCl  and 0.3 M Na:, citrate), 5 X Denhardt’s 
(100 X Denhardt’s, 2% (w/v) Ficoll 400, 2% (w/v) polyvinylpyrroli- 
done, 2% (w/v) bovine serum albumin, fraction V), 250 pg/ml of 
boiled sonicated  salmon  sperm  DNA, 0.5% (w/v) SDS, and 1% (w/v) 
glycine at 42 “C for  4  h. RatPDE3,  ratPDE4,  and  actin  cDNA clones 
were radiolabeled (33) using a random  primed labeling kit  and follow- 
incubated at  42 “C for 16-20 h with radiolabeled probe a t  1-2 X lo6 
ing the manufacturers’ instructions. The blots were consecutively 
cpm/ml of hybridization buffer (50% (v/v) formamide, 20 mM sodium 
phosphate (pH 6.5), 5 X SSC, 1 X Denhardt’s, 100 pg/ml of boiled 
sonicated  salmon  sperm  DNA, 0.5% (w/v) SDS, and 10% (w/v) 
dextran sulfate. The  membranes were washed twice for 20-30 min at  
65-68 in 0.1 X SSC, 0.1% (w/v) SDS and autoradiographed using 
intensifying screens. 
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Nuclear Run-off 
Nuclear run-off assays were performed basically as described (34). 
Isolation of Nuclei-Sertoli cells from 17-day-old male Sprague- 
Dawley rats were cultured in medium without serum. On the fourth 
day of culture the medium  was changed and  the cells were treated 
with 500 ng/ml of FSH for different lengths of time (0 min, 30 min, 
3 h, 24 h) or with 500 ng/ml of FSH, 1 mM B2cAMP, 100 p M  forskolin, 
or 100 ng/ml of cholera toxin for 3 h. After the appropriate incubation 
time  the medium  was  removed and  the cells were rinsed twice with 
ice-cold PBS. The cells were collected by scraping with a rubber 
policeman and centrifugation for 5 min at 500 X g. For each nuclear 
run-off reaction nuclei from approximately 5 X lo7 cells were prepared 
by  Dounce homogenization as described (34). 
Binding Plasmids to Nitrocellulose-Plasmids containing cDNA 
inserts of c-fos, ubiquitin, ratPDE3,  or ratPDE4 were linearized with 
the appropriate  restriction enzymes, phenol and chloroform ex- 
tracted,  and  ethanol precipitated. The linearized plasmids were de- 
natured  in 0.1 M NaOH for 30 min at room temperature and neutral- 
ized by addition of 10 volumes of 6 X SSC (20 X SSC, 3 M NaCl, 0.3 
M Na3 citrate). Five micrograms of each plasmid was spotted  onto 
nitrocellulose filters using a slot blot apparatus. The filters were 
baked for 2 h at 80 "C under vacuum. 
Nuclear Run-off Reactions-These reactions were performed as 
described (34) and  the total 3zP incorporation into newly transcribed 
RNA was estimated by scintillation counting. After hybridization to 
the nitrocellulose strips  containing the linearized immobilized plas- 
mids, the filters were washed twice in 2 X SSC for 1 h at 65 "C and 
single stranded unhybridized RNA  was digested by RNase A. After 
one more  wash in 2 X SSC at  37 "C for 1 h the filters were air-dried 
and exposed to x-ray film. The radioactive spots were excised from 
the membranes and counted. 
Immunoprecipitation 
Fixed Staphylococcus aureus cells (Pansorbin) were prewashed 
twice in PBS. For one immunoprecipitation 50 J of Pansorbin was 
incubated for 1 h on ice with an equal volume of polyclonal antiserum 
K l l l  (1/100 dilution in PBS plus 0.05% bovine serum albumin). This 
rabbit  antiserum was raised against  a  synthetic peptide (peptide 2224) 
based on the deduced amino acid sequence of ratPDE3,  but recognizes 
both recombinant ratPDE3  and  ratPDE4 proteins expressed in bac- 
teria or COS-7 cells. The Pansorbin-antibody complexes were washed 
once with 20 mM Tris. C1 (pH 7.8),  0.5 M NaCl and twice with 20 mM 
Tris.Cl  (pH 7.8). Soluble extracts from Sertoli cells from three 35- 
mm dishes were added to the Pansorbin-antibody complexes and 
incubated for  1.5 h on ice. After three washes with PBS  the Pansor- 
bin-antibody-antigen complexes were pelleted at 14,000 X g. The 
pellets were resuspended in 45 p1 of PBS containing 1% SDS and 
incubated at room temperature for 10 min to release the antibody- 
antigen complexes  from the Pansorbin. After centrifugation at  14,000 
X g the  supernatant was collected, 2 X sample buffer was added (1 X 
sample buffer, 62.5 mM Tris.Cl,  pH 6.8, 10% (v/v) glycerol, 2% SDS 
(w/v), 715 mM 2-mercaptoethanol, 0.0025% (w/v) bromphenol blue), 
and  the samples were subjected to SDS-polyacrylamide gel electro- 
phoresis. 
Western  Blot Analysis 
To cellular fractions or immunoprecipitates from Sertoli cells, 1 
volume of 2 X sample buffer was added. The samples were heated to 
100 "C for 5 min and subjected to electrophoresis in a 10% SDS- 
polyacrylamide gel. After electrophoresis the proteins were blotted 
onto an immobilon membrane which  was  blocked in  a PBS solution 
containing 0.05% (v/v) Tween 20 and 5% (w/v) dry nonfat milk. 
K l l l  antiserum at a dilution of 1/100 was incubated with the mem- 
brane in blocking buffer and afterwards rinsed three times with a 
PBS washing solution containing 1% (v/v) Nonidet P-40 and 0.2% 
(v/v) Tween 20. Finally, the membrane was incubated with '''1- 
labeled protein A (0.5 pCi/ml) in blocking buffer, rinsed 5 times with 
PBS washing solution, and autoradiographed. 
RESULTS 
Sequence Comparison of RatPDE3 and RatPDE4"As pre- 
viously reported (16), two groups of cDNA clones (ratPDE3 
and ratPDE4) were isolated from a cDNA library derived 
from cultured 15-day-old Sprague-Dawley rat Sertoli cells 
that had been treated with 500 PM Bt,cAMP (19). The DNA 
sequence of ratPDE4 (data not shown, submitted to Gen- 
Bank) is compiled of two independent cDNA clones from the 
unamplified library. No in-frame  termination codon 5' of the 
first ATG was found in the available ratPDE4 sequence. 
Therefore, it is not clear whether  this  first ATG is the correct 
start site. The sequence surrounding  this ATG in ratPDE4.1 
fits the Kozak consensus sequence since it has a purine in 
position -3 (35). The putative  ratPDE4 major open reading 
frame therefore encodes a  protein with a calculated molecular 
mass of  64.273 kDa or larger. The first  three codons following 
the most 5' ATG encode the same amino acids around the 
putative initiation codon in the ratPDE3.1 cDNA (Fig. 1). 
After a short stretch of unrelated sequences at the amino 
terminus, the similarity between ratPDE3  and  ratPDE4 re- 
sumes and continues for about 454 amino acids (453 for 
ratPDE3  and 455 for ratPDE4).  In  this region the sequence 
identity is 87%.  The carboxyl termini of both  putative  pro- 
teins  are less homologous although  both  are highly negatively 
charged (Fig. 1) and  contain sequences that fit the consensus 
sequence for phosphorylation by casein kinase I1 (36). Both 
putative proteins also contain a sequence of 4 consecutive 
basic amino acids, similar to  the nuclear localization signal of 
FIG. 1. Comparison of the deduced amino acid sequences of 
ratPDE3 and ratPDE4 from the rat Sertoli cell. Amino acid 
sequences of the major open reading frames deduced from ratPDE3 
(19) and ratPDE4 cDNAs were aligned. Amino acid residues are 
represented by the single letter code. Gaps have been introduced in 
the sequences to optimize the alignment. Regions of sequence identity 
have been boxed. Vertical arrowheads delineate the highly  homologous 
region of 455 amino acids. The underlined amino acid residues rep- 
resent the sequence of a  synthetic peptide (K111) that was used to 
raise polyclonal antibodies. A putative nuclear translocation signal 
sequence is indicated by small arrows. Horizontal arrowheads deline- 
ate  the region  of ratPDE4 shown in Fig. 2. Putative  sites for phos- 
phorylation by casein kinase I1 are indicated by asterisks. 
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the SV40 large T antigen  (37)  and  other  nuclear  proteins (38- 
42). 
A cDNA clone (DPD)  similar  to  the  ratPDE4  clones  has 
also been  isolated  from rat  brain (18). 525 codons of the  open 
reading  frame  and  the available 3"untranslated region of the 
ratPDE4  and  DPD clones are  identical (Fig. 2). The 5' por- 
tions of the  putative  open  reading  frames  are  unrelated (Fig. 
2). The 5' portion of our  ratPDE4 sequence was derived from 
two  independent  clones  (ratPDE4.1  and  ratPDE4.2) from a 
Sertoli cell unamplified library. In addition, the same se- 
quence was present in a genomic clone derived from a rat 
cosmid library  (data  not  shown),  ruling  out  the possibility of 
cloning  artifacts. 
Characterization of the Recombinant PDE  Activity Encoded 
by RatPDE4 and Comparison with  RatPDE3-The high de- 
gree of homology between the ratPDE3 and the ratPDE4 
sequences suggests that  both  enzymes  have  similar  kinetics 
and physicochemical characteristics. To  verify this possibility, 
both  PDEs were expressed in  prokaryotic as well as in  eukar- 
yotic cells. 
To  express  the  two  cDNAs  in E. coli, cDNAs were modified 
to  arrange the putative initiation methionine immediately 
after  the  ribosomal-binding  site of the  pRC23 vector. Trans- 
formation of E. coli DH5a  with  pRC23-ratPDE3  and  pRC23- 
ratPDE4 led to the appearance of major immunoreactive 
bands (with the K l l l  antibody, see "Experimental Proce- 
dures") of 71 and  68 kDa,  respectively (data  not  shown).  Less 
intense  immunoreactive  bands of lower molecular  weight were 
often recovered, suggesting degradation of the  recombinant 
protein. The immunoreactivity was associated  with  the  ap- 
pearance of high affinity  PDE  activity  in  the  bacterial lysates. 
cAMP hydrolysis by both  recombinant  enzymes followed Mi- 
chaelis-Menten kinetics and Lineweaver-Burke plots were 
linear with substrate  concentrations  ranging  between 0.1 and 
50 PM. The K ,  values for  cAMP  (Table  I) were similar for 
PDE4: M K E Q G G T V S G A G S S R G G G  0 D ~ A  H ~ L  Q ~ L  Q P N 
DPD : S L R I V R N N P T L L T N L H G A P N K R S P A A S Q A P  
PDf4: Y L S V C L F A E E S Y Q K L A H E T L E E L D W C L D  ..... 
DPD : V T R V S L  00 Q E E S Y Q K L A M E T L E E L D W C L D  I ..... 
FIG. 2. Comparison of the deduced amino acid sequences of 
ratPDE4 and DPD. Amino acid sequences of the major  open 
reading frames deduced from ratPDE4  and  DPD (18) cDNAs were 
compared  using  the MicroGenie align routine.  Amino acid residues 
of the  amino-terminal region of ratPDE4 (as delineated  in Fig. 1) and 
of the corresponding region of DPD  are  represented by the single 
letter code. Gaps have  been introduced in the  sequences to optimize 
alignments. Regions of sequence identity have  been boxed. 
TABLE I 
Comparison of the  properties of recombinant ratPDE3  and 
ratPDE4 expressed in  E. coli 
Properties Recombinant Recombinant ratPDE3 ratPDE4 
Calculated  molecular mass 66,249 Da 64,273 Da 
K,,, CAMP (phi)  1.9 2.5 
K,,, cGMP ( p M )  ND" ND 
Specific activity  extract 593 k 65 851 f 143 
SDS-PAGE 71 kDa  68  kDa 
(pmol/min. mg of pro- 
tein) 
Inhibitors (ED,) in pM) 
cGMP >50 >50 
Methylisobutylxanthine 18.5 f 2.0  21.0 f 3.0 
Rolipram 0.6 f 0.1 0.4 k 0.1 
1.6 f 0.9 1.2 & 0.2 
Cilostamide 38.6 f 5.1 29.0 f 2.7 
RO 20-1724 
" ND, not  detectable. 
both  PDEs (1.9 and 2.5 p~ cAMP for ratPDE3  and  ratPDE4, 
respectively). Velocity determined in crude extracts ranged 
between 0.5 and 1 nmol/min/mg of protein (Table I). In 
addition,  both  recombinant  enzymes displayed similar  sensi- 
tivities to a variety of PDE  inhibitors, rolipram and Ro 20- 
1724 being more  effective inhibitors  than cilostamide or mil- 
rinone  (Table  I). 
Since expression in prokaryotic cells does not allow the 
same  post-translational modifications as  in  eukaryotic cells, 
the two cDNAs were also expressed  in  monkey  kidney (COS- 
7) cells. Affinities  for cAMP of the two PDEs recovered from 
COS-7 cell transfection were very similar  to  those  determined 
from  the  bacterial  expression  (ratPDE3 K,, = 1.81; ratPDE4 
K,, = 2.85). However, although  Northern  and  Western blot 
analysis  indicated  that  transfection efficiency, transcription, 
and translation of the two constructs in COS-7 cells was 
comparable, differences were observed  in the  amount  and in 
intracellular  distribution of the  CAMP-PDE  activity  re- 
covered (PDE  activity  in picomoles/min . mg of protein ? S.E., 
n = 10: mock supernatant:  179 & 26; mock pellet: 49 & 15; 
ratPDE3 supernatant: 716 ? 90; ratPDE3 pellet: 171 k 25; 
ratPDE4  supernatant: 308 & 56; ratPDE4 pellet: 143 & 11). 
Further  experiments  are required to clarify these findings. 
Regulation of Steady  State mRNA Levels for RatPDI33 and 
RatPDE4  in Sertoli Cells-Previous biochemical characteriza- 
tion of the  Sertoli cell PDEs  indicated  that  rolipram-sensitive 
PDEs were present  in  this cell, mostly after  hormonal  stim- 
ulation (13). The  cloning  data suggested that mainly ratPDE3 
and ratPDE4 were expressed in the Sertoli cell (16). To  
further  assess  this possibility, Sertoli cell mRNA was  hybrid- 
ized to the  PDE  cDNA clones  available. These  Northern blot 
analyses indicated that  ratPDE3  and  ratPDE4  are  the two 
dominant ratPDEs expressed in these cells, and that the 
cAMP  analog  treatment  has  major effects on mRNA levels. 
Sertoli cells  from  15-day-old rats  cultured for 4 days in defined 
medium expressed ratPDE3  mRNA levels that were at  the 
limit of detection by Northern  blot  analysis (Figs. 3 and  4). 
After 24 h treatment with the cAMP analog Bt, CAMP, 
however, the ratPDE3 steady state transcript level is in- 
creased a t  least 100-fold  (19). To  test  if this is also the case 
dbcAMP 
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FIG. 3. Regulation of ratPDE3 and ratPDE4 steady state 
mRNA levels by dibutyryl cAMP in  the rat  Sertoli cell. Sertoli 
cells from 15-day-old Sprague-Dawley rats were cultured for 4 days 
in medium without serum (26). The cells were incuhat.ed in the 
absence  or presence of 0.5 mM Bt,cAMP. After 24 h, poly(A)' RNA 
was prepared  and  (5 pg) separated on  a 1% agarose gel, blotted, and 
hybridized with '"P-labeled ratPDE3 cDNA and autoradiographed. 
After removal of the probe, the membrane was rehyhridized with 
ratPDE4 cDNA and consecutively with actin cDNA. Size markers 
were radiolabeled HindIII-digested X DNA fragments. 
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FIG. 4. Dose dependence of the FSH stimulation of ratPDE3 
a n d   r a t P D E 4   s t e a d y  state mRNA  levels   in  the rat Sertoli  cell. 
On  the  fourth  day of culture in defined  medium, primary  Sertoli cells 
were  rinsed and  incubated for 24 h with  increasing  concentrations of 
FSH.  Total RNA was  prepared,  separated  on a 1% agarose gel, blotted 
onto a nylon membrane, and hybridized with :"P-labeled ratPDE3 
cDNA  and  autoradiographed. After  removal of the probe, the  mem- 
brane was rehybridized with  ratPDE4  cDNA  and consecutively with 
actin cDNA. The  mRNA  abundance  as  determined by densitometric 
scanning of the  autoradiograms  are expressed in  arbitrary  units. 
4.Okb". - - - - ~ - - ~ ~ y - ~ q w - - ~  rotPDE4 J .  
FIG. 5. T ime  course  of the   regulat ion of the ratPDE3 and 
ra tPDE4   s t eady  state mRNA  levels by FSH in the rat Sertoli 
cell.  Sertoli cells  from  15-day-old  Sprague-Dawley rats were cultured 
in defined  medium.  On the  fourth  day of culture  the cells were treated 
with 100 ng of FSH/ml of medium. A t  the  indicated  times  total  RNA 
was prepared. Ten micrograms of RNA of each time point was 
glyoxylated and  separated  on a 1% agarose gel. After blotting  onto a 
nylon membrane  the  blot was hybridized with '"P-labeled ratPDE3 
cDNA and  autoradiographed. After removal of the  ratPDE3 probe, 
the membrane was rehybridized with radiolabeled ratPDE4 cDNA 
and autoradiographed. 
for  ratPDE4,  the  same  Northern  blots were hybridized with 
radiolabeled ratPDE4  cDNAs of similar specific activities  as 
the ratPDE3 cDNAs and autoradiographed. The ratPDE4 
steady  state  transcript level was readily detectable  under  basal 
conditions  and was  increased  only about 5-fold as determined 
by spectrophotometric scanning (Fig. 3). These differences 
were confirmed in several other  Northern  blot  experiments 
from independent  Sertoli cell cultures  and were also  evident 
after  FSH or forskolin treatment (Figs. 4 and 5, and  data  not 
shown).  The  increase  in  steady  state levels of ratPDE3  and 
ratPDE4 mRNA by FSH is dose-dependent and occurs a t  
physiological concentrations of FSH  ranging between 1 and 
100 ng/ml. Whereas ratPDE4 mRNA levels were maximal 
upon exposure of the cells to  10  ng of FSH/ml of medium, 
ratPDE3  mRNA levels could  be further  elevated  with higher 
FSH  concentrations (Fig. 4). 
When Sertoli cells were exposed to  FSH,  the  AMP-PDE 
activity increases after a time lag of 1 h and reaches a 
maximum a t  18-24 h (15). The  time course of changes  in  the 
ratPDE steady state mRNA levels in primary Sertoli cell 
cultures treated with 100 ng/ml FSH is reported in Fig. 5. 
After a time lag of about 1 h the level of transcripts  increased, 
reached a maximum  between  3 and 12 h,  and  then gradually 
decreased to near basal levels in a time span of 3 days. 
Confirming the above reported data, ratPDE4 transcripts 
were present under basal conditions, while ratPDE3 tran- 
scripts were not  detectable  under  these  experimental condi- 
tions. 
Marked differences in hormone dependence of the two 
PDEs were also  present when rats were treated with FSH in 
vivo. Whereas  ratPDE3  mRNA levels undergo  a  large  increase 
after  FSH  injection,  no  significant  changes in ratPDE4 
mRNA could be detected under these conditions (data not 
shown). 
Regulation of Transcription of RatPDE3 and RatPDE4- 
To  test  whether  the differences in regulation of steady  state 
mRNA levels for ratPDE3  and  ratPDE4  are caused by differ- 
ences in mRNA  stability  or by differential regulation of gene 
transcription, nuclear run-off assays were performed. The 
rate of transcription of c-fos and  ubiquitin was measured as 
positive and negative control for the  FSH effects. In  the  three 
different  experiments  performed,  Sertoli cell nuclei isolated 
prior  to  FSH  treatment showed low levels of ratPDE3  and 
ratPDE4  transcription  (Table 11). The  transcription  rate of 
ratPDE3  increased  earlier  than 30 min  after  FSH  treatment, 
reached a maximum a t  3 h,  and  returned  towards basal within 
24 h. The  rate of transcription of ratPDE4 did not signifi- 
cantly  change  during  the  time period studied.  Furthermore, 
dibutyryl CAMP, forskolin, and cholera toxin produced an 
increase  in  the  ratPDE3  rate of transcription  similar  to  FSH 
(Table 111). This  indicates  that  hormone ffects on  PDE gene 
TABLE I1 
Time course of FSH regulation of ratPDE3 and  ratPDE4  rate 
of transcription 
Nuclear run-off assays were performed  as described under  "Exper- 
imental Procedures." Five micrograms of plasmids containing rat- 
PDE3, ratPDE4, c-fos, or ubiquitin cDNAs were immobilized on 
nylon  filters. Sertoli cells  from  17-day-old  Sprague-Dawley rats were 
treated with 500 ng/ml of FSH for the indicated lengths of time, 
nuclei  were prepared,  and  incubated  with  [n-'"P]UTP.  The  total :'T 
incorporation  into newly transcribed  RNA was estimated by scintil- 
lation counting. After hybridization to the nylon strips containing 
the plasmids, the  filters were washed and exposed to  x-ray film. The 
radioactive spots were excised from the membranes and counted. 
These counts were divided by the total number of counts in the 
hybridization solution to express the rate of transcription  in  parts 
per million. The rate of transcription of c-fos and ubiquitin was 
measured as positive and negative control for the  FSH effects. 
Specific RNA concentration after FSH 
addition Immobilized 
DNA 
0 90 min 3 h  24 h 
PPm 
RatPDE3 ND" 3.97 12.93 1.07 
RatPDE4 1.19 0.63 1.15 0.83 
c-fos 2.17 19.31 10.27 2.65 
Ubiquitin 6.07 3.03 4.03 4.03 
" ND,  not detectable. 
TABLE I11 
Regulation of ratPDE3  and  ratPDE4  rate of transcription by FSH, 
&CAMP, forskolin,  and cholera toxin 
Nuclear run-off assays were performed as described in Table 11. 
Sertoli cells  from  17-day-old  Sprague-Dawley rats were incuhated in 
the  presence or absence of 500 ng/ml FSH, 1 mM Bt,cAMP,  100 pM 
forskolin, or 100 ng/ml  cholera toxin for 3 h. 
Immobilized 
Specific RNA concentration 
DNA None FSH Rt,cAMP Forskolin 
ppm 
RatPDE3 0.88 8.31 10.54 8.69 8.80 
RatPDE4 1.57 2.08 2.68 3.01 2.51 
Uhiquitin 4.15 2.00 2.43 2.93 2.53 
c-fos 2.48 7.48 8.73 8.74  9.04 
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FIG. 6. Immunoblot analysis of soluble fractions ( A )  and 
partially  purified CAMP-PDE preparations ( B )  from the rat 
Sertoli cell with K l l l  antiserum. On the fourt,h day of culture 
in defined  medium, primary  Sertoli cells  were incubated in the  pres- 
ence or absence of 1 mM Bt2cAMP for 24 h. The cells were scraped 
with a rubber policeman and homogenized in an all-glass Dounce 
homogenizer.  After fractionation of the cell extract by centrifugation 
a t  14,000 X g for 15  min,  the  supernatant  proteins ( A )  and a CAMP- 
PDE protein  preparation,  partially purified  from the  rat  Sertoli  celp 
( R ) ,  were subjected to  SDS-polyacrylamide gel electrophoresis.  After 
blotting  onto nylon membranes,  duplicate  blots were incubated with 
the K l l l  antiserum  (raised  against a synthetic  ratPDE  peptide) or 
with  the K l l l  antiserum  preincubated with excess  peptide used  for 
immunizations.  Immunoreactive  proteins were  visualized by incubat- 
ing  the  blots with "'1-labeled protein A and  autoradiography. 
transcription  are  mediated by the  activation of the  CAMP- 
dependent pathway. 
Regulation of the RatPDE Protein Levels-To determine 
whether  the  increase  in  ratPDE  mRNA  results  in  an  increase 
in  PDE  protein  content,  Sertoli cell extracts were  subjected 
to  immunoblot analysis.  A  polyclonal antiserum (K111)  was 
raised  against a synthetic  peptide  based  on  the sequence of 
ratPDE3.  This  antiserum recognizes both  recombinant  rat- 
PDE3 and ratPDE4 proteins (data not shown). Although 
immunoblot analysis of crude Sertoli cell extracts showed 
several  bands, only the  signals of a 67 and a  54-kDa  polypep- 
tide were abolished  by competing  the  antibody  with  the pep- 
tide used for immunization (Fig. 6A). The 67-kDa protein 
level was markedly affected by Bt'cAMP treatment, being 
undetectable  in  extracts  from  unstimulated  Sertoli cells (Fig. 
6A). To  confirm that  the 67-kDa  protein  corresponds  to  the 
CAMP-PDE,  extracts  from  stimulated  Sertoli cells were par- 
tially purified by high performance liquid chromatography' 
and  the  peak  fraction of CAMP-PDE  activity was  subjected 
to  immunoblot analysis. Under these conditions only the 
immunoreactivity of a  67-kDa  polypeptide  was present  and 
the signal  was  competed  by the  peptide (Fig. 6B). Using an 
alternative  approach  to  increase  the  immunoblot signal,  sol- 
uble  extracts from control,  FSH-,  or  dibutyryl CAMP-stimu- 
lated Sertoli cells were first immunoprecipitated with the 
K l l l  antiserum,  and  the  immunoprecipitated  proteins were 
' M. Conti, J. Odeh, J. V. Swinnen,  and M. E. Svoboda, submitted 
for publication. 
analyzed  by immunoblotting.  Even  after  enriching  the  PDE 
protein by immunoprecipitation,  no  detectable  band could be 
observed under basal conditions (Fig. 7A). Conversely, an 
immunoreactive  67-kDa  band  appeared  after  FSH  and dibu- 
tyryl  cAMP  treatment (Fig. 7A). The  intensity of these  bands 
correlated  with  the levels of CAMP-PDE  activity measured  in 
the supernatants before immunoprecipitation (Fig. 7B). Fi- 
nally, the size of this  band was identical  to  that of a  purified 
CAMP-PDE  from  the  Sertoli cell (Fig. 7A).' 
DISCUSSION 
Biochemical characterization  and molecular  cloning of the 
CAMP-PDEs  has uncovered an unexpected  complexity of this 
family of enzymes. In  the  rat  there  are  at  least four genes 
encoding  cGMP-insensitive,  rolipram-  and  Ro 20-1724-inhib- 
ited  CAMP-PDEs (16), and  data suggesting alternate splicing 
open  the possibility to expression of an even larger number 
of PDE  proteins (16, 17, 19).  Transcripts derived from two of 
these genes (ratPDE3  and  ratPDE4)  are  present  in  the  rat 
Sertoli cell in culture.  Although  differences in  basal levels and 
in  the degree of hormone  stimulation  are  present,  the  expres- 
sion of both  ratPDE3  and  ratPDE4  is  under  the  control of 
follicle-stimulating hormone  and  CAMP.  The  data  presented 
here demonstrate that the increase in cAMP hydrolyzing 
activity observed in this cell is  the  result of an increase in 
rate of CAMP-PDE gene transcription,  accumulation of 
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FIG. 7. Regulation of CAMP-PDE protein levels ( A )  and 
cAMP hydrolyzing activity ( B )  by FSH and  dibutyryl cAMP 
in the soluble fraction of the rat Sertoli cell. Sertoli cells from 
15-day-old Sprague-Dawley rats were cultured in defined medium. 
On  the  fourth  day of culture  the cells were incubated  in  the presence 
or absence of 500 ng/ml FSH or 1 mM Bt2cAMP.  Twenty-four  hours 
after  the  additions  the cells were scraped with a rubber policeman 
and homogenized in an all-glass  Dounce homogenizer. This cell 
extract was fractionated by centrifugation a t  14,000 X g for 15 min. 
The  supernatant  fractions were  subjected to  PDE assays and immu- 
noprecipitation and the anti-CAMP-PDE antibody K111. The im- 
munoprecipitated  proteins were  solubilized and  separated  on a 10% 
polyacrylamide gel. CAMP-PDE  protein purified from the  rat Sertoli 
cell2  was  loaded on  the  same gel. After blotting  onto a nylon mem- 
brane,  the  blot was incubated with the K l l l  antibody  and ""I-labeled 
protein A and  autoradiographed. 
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data,  then, provide  evidence  for  a novel mechanism of regu- 
lation of PDEs that involves hormone-dependent CAMP- 
mediated  changes  in  the  rate of a PDE gene transcription. 
A  molecular  cloning approach  has  demonstrated  that  the 
Sertoli cell expresses ratPDE3  and  ratPDE4. As previously 
shown (19), ratPDE3 encodes a protein with a calculated 
molecular mass of  66.2 kDa, while conceptual  translation of 
the  ratPDE4  cDNAs  is  consistent  with a PDE  protein of  64.2 
kDa or higher molecular mass. Although no in-frame up- 
stream  termination codon  was found  in  the cDNA  clones that 
we have available, preliminary sequence available from a 
genomic  clone demonstrates  the  presence of a stop codon  108 
bases  upstream from the  putative  initiation  methionine. 
Nevertheless, further studies are needed to unequivocally 
prove that the ATG that we have selected codes for the 
initiation  methionine  also in uiuo. On the  other  hand,  these 
CAMP-PDEs might  have multiple  initiation  methionines (17). 
The  ratPDE4  cDNAs isolated from  the  rat  Sertoli cell  cDNA 
library have  sequences identical  to  the  DPD clone isolated by 
complementation from  a rat  brain  library  except for the  first 
40 amino acids of the putative open reading frames (18). 
Although  cloning artifacts  cannot be completely  excluded, it 
is possible that  alternate splicing of a single ratPDE4 gene 
occurs in  brain  and  testis. Evidence  suggesting alternate splic- 
ing or multiple start  sites  have  also  been  reported for other 
CAMP-PDE encoding cDNAs (17, 19). In  addition,  most cell 
types studied express multiple transcripts of the ratPDE 
genes,  some of which are  tissue specific (16).  There is, then, 
potential for the  expression of a large number of rolipram- 
sensitive CAMP-PDEs. That alternate splicing might be a 
property of PDEs is also suggested by data on other  PDE 
families. It  has been reported  that two distinct  amino  termini 
have been found  for  a Ca2+/calmodulin-dependent PDE  (43). 
Based on the sequence similarity  in  the  central  portion of 
the proteins, it was expected that  the  kinetic  properties of 
both enzymes are very similar.  This was confirmed  here by 
prokaryotic expression of the two PDEs.  The two enzymes 
have a similar K,,, for cAMP  and  similar  sensitivity  to  different 
inhibitors. Therefore, the catalytic centers are structurally 
and  functionally very similar. I t  is possible that  the  amino 
and carboxyl termini, being different in the two proteins, 
serve  different  functions  in  the two CAMP-PDEs. 
Both  ratPDE3  and  ratPDE4  transcript  steady  state levels 
were increased by FSH  after a lag of about 1 h and  remained 
elevated for at  least 2 days. This is in agreement with the 
appearance of the  cAMP hydrolyzing activity  in  the  Sertoli 
cell supernatant  (15).  The increase in  ratPDE3  mRNA levels 
in response to Bt,cAMP or FSH was consistently larger than 
that of ratPDE4. Nuclear  run-off experiments showed that a 
10-fold increase in the rate of ratPDE3 gene transcription 
followed FSH  treatment in uitro. Conversely, the  basal  tran- 
scription  rate of ratPDE4 was at the  limit of detection  and 
FSH activation of transcription was small  and  not  significant. 
I t  is,  then, possible that  also  mRNA  stabilization  plays a  role 
in  the regulation of the  steady  state  mRNA levels of these 
genes. The  FSH effect on the  ratPDE gene transcription  is 
mimicked by cAMP analogs and other cAMP increasing 
agents,  indicating  that  this  hormonal  activation f transcrip- 
tion is mediated by CAMP. Transcriptional activation of 
cAMP responsive  genes such  as c-fos is commonly thought  to 
occur via CAMP-dependent phosphorylation of cAMP re- 
sponse element-binding proteins (44) or by regulating the 
levels of trans-acting  factors  that  bind  to  the  AP1  and/or  AP2 
elements (45, 46). Similar regulatory sequences  can  therefore 
also be expected in the 5’-flanking region of the  ratPDE3 
gene. It is worth noting, however, that the time course of 
ratPDE3 gene transcription  is slower than  that observed  for 
c-fos. The  transcription of c-fos reaches a maximum at the 
30-min  time  point, while ratPDE3  transcription  peaks only 
after 3  h. I t  is  then  to be expected that  the  FSH-dependent 
CAMP-mediated transcription of the two  genes  involves  dif- 
ferent steps. Although the basic mechanism might be the 
same, e.g. phosphorylation of a cAMP response element- 
binding  protein,  additional regulatory steps  either delay the 
activation of ratPDE3 gene transcription, or cause a more 
rapid  termination of c-fos transcription.  The possibility 
should also be considered that  the c-fos gene product might 
be involved in  the  modulation of transcription of the  ratPDE3 
gene. In  fact,  the  c-fosljun complex is a transcription  activator 
that  binds  to  an  AP-1  regulatory  element  (45),  and  hormonal 
activation of the  Sertoli cell leads  to  increased levels of both 
fos andjun  mRNAs  (47). 
The  finding  that  cAMP  regulates  the expression of CAMP- 
PDEs  explains  earlier  reports on cell lines  with  diminished 
protein kinase A and phosphodiesterase activity. The kin- 
and  PPD  mutant  strains of S49  lymphoma cells, for instance, 
have a  decreased protein  kinase A activity  in comparison with 
the wild type cells. The kinase defect is associated with a 
decrease in  cAMP hydrolytic activity,  indicating  that  protein 
kinase A mediates, probably  by  regulating transcription fac- 
tors,  the  expression of certain  PDE  forms (48, 49). 
The hypothesis that CAMP-PDE activation is dependent 
on new synthesis of the  PDE  protein  is here proven by the 
use of polyclonal antibodies.  It is, however, still possible that 
additional modifications such as phosphorylation  are neces- 
sary to express the full activity of the PDE. One puzzling 
finding  is  that  although  ratPDE4  mRNA  is expressed in  the 
Sertoli cell under  basal  conditions,  no  immunoreactive  PDE 
protein could be  detected  in  the  Sertoli cell soluble fraction. 
I t  is possible that ratPDE4 protein levels are below the 
sensitivity of the immunodetection employed in our study. 
An alternative possibility is  that  the  ratPDE4  protein  is  not 
present  in  the soluble  cell fraction,  but  compartmentalizes in 
other subcellular districts.  This  latter possibility would also 
reconcile differences found in the stimulated Sertoli cell. 
While high levels of both  ratPDE3  and  ratPDE4  mRNA  are 
present under these culture conditions, only one immuno- 
reactive band could be  detected even after  immunoprecipita- 
tion.  Other  reports  have  demonstrated  the presence of a low 
K,,, CAMP-PDE  in  the  particulate  fraction of the  brain (50). 
Consistent  with  this view also  is  the  finding  that  rolipram 
binding  to  membrane-bound  sites was detected  in  brain (51). 
Also in  the  rat liver,  a membrane-bound  PDE is sensitive  to 
rolipram (52, 53). 
The  time  course of this CAMP-mediated activation of these 
CAMP-PDEs in the Sertoli cell is very different from that 
described for the CAMP-dependent activation of a cGMP- 
inhibited PDE from human  platelets (54-56) and  rat  adipo- 
cytes (57, 58). This latter enzyme is membrane bound and 
very  rapidly activated by phosphorylation.  In a cell where the 
two modes of regulation coexist, there will be a complex 
pattern of PDE activation,  with early and delayed increases 
in  PDE activity. The  exact significance of this complexity is 
unclear,  but  there  is evidence that  the long term  PDE  acti- 
vation  is involved in  the regulation of the  hormone  respon- 
siveness of the  Sertoli cell (15). The homologous and  heter- 
ologous desensitization of the rat Sertoli cell is in part or 
completely  reverted after  inhibition of the  PDEs by Ro 20- 
1724 (13). This indicates that these CAMP-PDEs serve to 
control  the responsiveness of the  Sertoli cell to  hormones.  On 
the other hand, experiments with in uitro model systems 
containing hormone-sensitive adenylate cyclase, CAMP-de- 
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pendent  protein kinase 11, and cyclic nucleotide phosphodi- 
esterase support the hypothesis that rapid cAMP turnover 
may function as  a mechanism for signal amplification by the 
CAMP-dependent protein kinase (59). These hypotheses can 
now be tested by studying other hormone-responsive cell 
systems that express a different subset of CAMP-PDEs  and 
by stable  transfection of hormone-responsive cell lines with 
the available CAMP-PDE cDNAs. 
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